Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. (also referenced as Quoin Pharmaceuticals, Ltd. in metadata) for the month of July 2019. The filing reports on the status of the Company's Annual General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding a shareholder meeting and does not contain financial statements.
Material Changes
There are no material financial changes reported in this document. The primary event is the adjournment of the Annual General Meeting of Shareholders originally scheduled for July 30, 2019, due to a lack of quorum.
Outlook and Management Commentary
The Company has reconvened the Annual General Meeting of Shareholders for Monday, August 6, 2019, at 11:00 a.m. (Israel time). The meeting will be held at the offices of the Company's legal counsel, Doron, Tikotzky, Kantor, Gutman, Nass & Amit Gross, located at B.S.R 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak. No specific business outlook, risks, or contingencies were detailed in this filing.
Key Facts for Investors
- The Annual General Meeting scheduled for July 30, 2019, was adjourned due to a lack of quorum.
- The meeting is rescheduled for August 6, 2019, at the same time and location as the original meeting.
- This filing contains no financial performance data or updated guidance.
- The registrant files annual reports under Form 20-F.